Post

The trial will assess the biological and clinical activity of NP137 as an add-on therapy in solid tumours patients.

The initial interim data from the trial is anticipated by the end of the first quarter of next year.

The FDA could approve the first treatment for Friedreich’s ataxia, and at least three other major trials have readouts expected by year end.

An oral TRβ agonist, ABX-002 had shown target engagement in areas of the brain linked to depression.

The platform has been launched to accelerate the onboarding of clinical trial sites.

The trail will assess EXS-21546 along with anti-PD-1 therapy in relapsed or refractory RCC and NSCLC patients.

Trialmap helps participants to view data on the trial and receive reminders for appointments.

Only around two in three individuals with schizophrenia are diagnosed by a physician, likely due to misdiagnosis of the condition.

The blood thinning therapy caused major bleeding that led to the discontinuation of the treatment in these patients.

The project is based on a technology platform and comprises 27 partners from 17 EU and non-EU Member States.

The trial will assess the safety and efficacy of Diamyd in recently diagnosed type 1 diabetes patients.

Anticipated to enrol ten to 20 subjects, the trial will be carried out at the U of A.

The trial is anticipated to commence in the first half of next year.